Back to
RENAISSANCE TECHNOLOGIES LLCWEWEK
WEWEK18 quarters
Position history for
RENAISSANCE TECHNOLOGIES LLC's holdings in ZIOPHARM ONCOLOGY INC
As of its Q4 2023 13F, Renaissance Technologies held 382,000 shares of WEK (Ziopharm Oncology), worth $27,000.
Final Value
$0
Final Shares
0
Total Value Change
-$559,000
Total Shares Change
-130,605
Quarter-by-Quarter History
Other major holders of WEK: MSD Partners, L.P., MILLER VALUE PARTNERS, LLC